LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

McKesson Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

842.08 -0.48

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

841.45

Max

849.07

Pagrindiniai rodikliai

By Trading Economics

Pajamos

426M

1.2B

Pardavimai

5.3B

103B

P/E

Sektoriaus vid.

26.881

105.69

Pelnas, tenkantis vienai akcijai

9.86

Dividendų pajamingumas

0.35

Pelno marža

1.173

Darbuotojai

43,000

EBITDA

212M

1.5B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+8.77% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.35%

2.37%

Kitas dividendų mokėjimo data

2026-01-02

Kita Ex Dividend data

2025-12-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

4B

106B

Ankstesnė atidarymo kaina

842.56

Ankstesnė uždarymo kaina

842.08

Naujienos nuotaikos

By Acuity

12%

88%

9 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

McKesson Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-14 17:45; UTC

Uždarbis
Pagrindinės rinkos jėgos

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025-11-14 17:31; UTC

Uždarbis
Pagrindinės rinkos jėgos

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025-11-15 18:03; UTC

Uždarbis

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

2025-11-15 15:43; UTC

Uždarbis

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

2025-11-15 12:00; UTC

Uždarbis

Meta Opens Pop-Up Stores to Build Buzz for Its AI Glasses -- WSJ

2025-11-15 09:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-15 09:20; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2025-11-15 00:08; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

2025-11-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

2025-11-14 23:02; UTC

Rinkos pokalbiai

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

2025-11-14 22:35; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

2025-11-14 22:32; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

2025-11-14 22:29; UTC

Uždarbis

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

2025-11-14 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

2025-11-14 21:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-14 21:18; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

2025-11-14 20:27; UTC

Rinkos pokalbiai

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

2025-11-14 20:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

2025-11-14 20:17; UTC

Įsigijimai, susijungimai, perėmimai

Several State Attorneys General Oppose Railroad Merger -- WSJ

2025-11-14 19:29; UTC

Rinkos pokalbiai
Uždarbis

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

2025-11-14 18:44; UTC

Rinkos pokalbiai
Uždarbis

Disney's Growth Now Hinges More on ESPN -- Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

2025-11-14 18:20; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai
Uždarbis

Auto & Transport Roundup: Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2025-11-14 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-11-14 16:51; UTC

Rinkos pokalbiai

Starbucks Gets Holiday Sales Lift -- Market Talk

2025-11-14 16:48; UTC

Rinkos pokalbiai

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

2025-11-14 16:38; UTC

Rinkos pokalbiai

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

Akcijų palyginimas

Kainos pokytis

McKesson Corp Prognozė

Kainos tikslas

By TipRanks

8.77% į viršų

12 mėnesių prognozė

Vidutinis 915.92 USD  8.77%

Aukščiausias 1,000 USD

Žemiausias 775 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines McKesson Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

15 ratings

13

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

681.92 / 707.28Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

No Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

9 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat